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Letters to the Editorafter reoperative CABG2 is indeed
analogous (or similar) to that we re-
ported previously after primary
CABG.3 In that respect, we believe
that the reported survival comparisons,
derived for a general cardiac surgical
population (as opposed to selected ran-
domized, controlled trials), are rather
self-explanatory and were based on
rigorous analyses applying propensity
modeling and matching methods.
Nezic and colleagues asserted that
the reported comparative RA and SV
patency data in the literature do not
support the contention that the ob-
served survival benefit is the result of
RA patency being superior to that of
SV.1 Here, we believe that it is appro-
priate to warn against an imbalanced
choice of cited literature. Specifically,
Nezic and colleagues1 cited only arti-
cles suggesting that RA and SV exhibit
similar late patency,4-6 ignoring any
other data that showed superior RA pa-
tency.7 Interestingly, no studies of su-
perior SV to RA patency were cited
in their letter. Also, any discussion of
SV graft durability should not ignore
the sobering SV patency results re-
ported in the PREVENT IV Trial.8 Fi-
nally, we do agree that providing
patency data that parallel the survival
data findings would be an important
addition to some of the survival analy-
ses reported by us and by others. At the
same time, we believe that rigorous
analyses showing, in the general car-
diac surgical population, compelling
data regarding the potential survival
advantagewhenRA is used as a second
arterial conduit in CABG should not be
glossed over.
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To the Editor:
We read with interest the recent arti-
cle of Medalion and coworkers titled
‘‘The Effect of Cardiac Angiography
Timing, Contrast Media Dose, and
Preoperative Renal Function on Acute
Renal Failure After Coronary Artery
Bypass Grafting.’’1 The authors found
that both high contrast dose at angiog-
raphy (>1.4 mL/kg), and an operation
done up to 5 days after angiography
were independent risk factors for post-
operative acute renal failure (ARF) in
patients who underwent coronary
artery bypass grafting.ardiovascular Surgery c October 2010The authors found partially differ-
ent results with respect to a similar
study that we published in 2008.2 In
that study, we identified that an opera-
tion done on the same day as the an-
giogram was an independent risk
factor for ARF after surgery. A high
contrast dose (>1.36 mL/kg) was
univariately but not independently
associated with ARF. Medalion and
coworkers1 hypothesized that this par-
tial discrepancy may result from the
dichotomization of the contrast dose
based on the median value (whereas
they used the upper quartile) and the
use of peak creatinine for the defini-
tion of ARF (peak creatinine twice
the baseline value and >2 mg/dL),
whereas they used a 25% decrease of
estimated creatinine clearance and cre-
atinine clearance of 60 mL/min or less
on day 3.
We think that the main difference
between the 2 studies is the definition
of ARF. Medalion and coworkers1
used a more liberal definition (stage 1
of the RIFLE [risk, injury, failure,
loss, end-stage kidney disease] crite-
ria)3 and ended up with a quite high
ARF rate (13.6%), whereas our defini-
tion was more restrictive (stage 2 of the
RIFLE criteria) and led to an ARF rate
of 5.7%. Of course, a multivariable
analysis with more events as the out-
come variable is more likely to accept
more independent variables. To check
for this hypothesis, we have reana-
lyzed our data using the same liberal
definition of ARF dichotomizing the
contrast dose at the upper quartile of
the distribution (1.7 mL/kg).
The results of this new analysis are
reported in Table 1. A high dose of
contrast agent is now an independent
risk factor for ARF. However, only
operations done on the same day as
the angiogram carry an independent
association with ARF. Therefore, the
discrepancy between our study and
the one of Medalion and coworkers1
remains, with respect to the ‘‘safe’’
time that should be applied between
the angiogram and the operation.
It is certain that contrast-induced
TABLE 1. Acute renal failure risk
Factor Regression coefficient Odds ratio (95% CI) P value
Constant 4.16
Angiography on the operation day 0.702 2.02 (1.07–3.8) .030
Age (y) 0.047 1.05 (1.02–1.08) .001
Ejection fraction (%) 0.040 0.96 (0.94–0.98) .001
CPB duration (min) 0.016 1.016 (1.01–1.02) .001
High contrast dose 0.592 1.81 (1.01–3.23) .045
CI, Confidence interval; CPB, cardiopulmonary bypass.
Letters to the Editornephropathy peaks 3 to 5 days after
contrast administration, in the usual
‘‘noncardiac surgical’’ clinical model.
However, we must consider that the
cardiac operation may introduce im-
portant changes, with the widely
known detrimental effect of cardio-
pulmonary bypass, hemodilution,
loss of pulsatility, and possible low
cardiac output state on renal function.
All these factors may certainly
change the time-related onset of a con-
trast-induced nephropathy, and it is
surprising that cardiopulmonary by-
pass time is not an independent risk
factor for ARF in the authors’ model.
Nevertheless, we believe that this
study offers an important clinical mes-
sage, highlighting the deleterious renal
effects of a high contrast dose and
a short interval of time between the
angiogram and the coronary operation.
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It is with pleasure that I respond
to Ranucci and Ballotta regarding the
article ‘‘The Effect of Cardiac Angiog-
raphy Timing, Contrast Media Dose,
and Preoperative Renal Function on
Acute Renal Failure After Coronary
Artery Bypass Grafting.’’1 Indeed,
the studies of Ranucci,2 Del Duca,3
and their associates served in part as
the trigger for our study. In their orig-
inal article, Ranucci and associates2
identified operation done on same
day as the angiogram to be an indepen-
dent risk factor for acute renal failure
(ARF). However, contrast dose greater
than 1.36 mL/kg did not turn out to be
an independent risk factor. The preva-
lence of ARF in their series was 5.7%
(based on ARF definition of peak cre-
atinine twice the baseline value and
>2 mg/dL). In our study,1 ARF was
present in 13.6% (based on ARF def-
inition of 25% decrease of estimated
creatinine clearance and creatinine
clearance [eClCr] of 60 mL/min or
less on day 3), and both contrast dose
greater than 1.4 mL/kg, and operation
up to 5 days after angiography turned
out to be independently associated
with ARF. Ranucci and Ballotta
hypothesized that the differences are
secondary to different ARF defini-
tions, and they reanalyzed their data
with a more liberal definition of ARF
and higher contrast dose. Now, con-of Thoracic and Cardiovascular Surgetrast dose turned out to be an indepen-
dent predictor of ARF, but operation
performed later than the same day as
the angiogram failed to show any inde-
pendent association with ARF. Inas-
much as the definition of ARF is not
standardized, I agree that it is difficult
to compare different studies with
different definitions.Warnock,4 in a re-
cent editorial, challenges the subject
and call for standardization. Ranucci
and Ballotta are to be congratulated
for reanalyzing their data with ARF
definition close to the one my col-
leagues and I used (although not simi-
lar, inasmuch as we used eClCr and
they used creatinine for definition).
Differences in definition remain an is-
sue, although I believe other factors
may influence the differences between
the results. As we discussed in our
manuscript, we studied isolated first
time coronary artery bypass grafting
only, in contrast to Ranucci and asso-
ciates,2 who included several types of
operations in their study, including
reoperations, valve surgery, and other
operations that were already identified
elsewhere as risk factors for develop-
ment of ARF. Some of those more
complex operations are associated
with multiple comorbidities and end
up usually with longer cardiopulmo-
nary bypass time that may be a marker
of complexity. This may explain why
we did not identify cardiopulmonary
bypass as a predictor of ARF. Those
more complex cases and other cases
in which ARF developed as part of
a broader multiorgan failure (sepsis,
low cardiac output, and others) are
not directly related to time after angi-
ography but are captured as such
owing to the use of peak creatinine as
the reference point for ARF definition.
We elected to use creatinine on post-
operative day 3 as the reference point
to try to minimize capturing ARF not
related directly to timing of angiogra-
phy. It is also of interest that in the
Ranucci study, diabetes and preopera-
tive renal failure were not associated
with postoperative ARF (both vari-
ables are strongly associated withry c Volume 140, Number 4 943
